Search Results - "Pichard, A."

The accuracy of the FIB‐4 index for the diagnosis of mild fibrosis in chronic hepatitis B by MALLET, V., DHALLUIN‐VENIER, V., ROUSSIN, C., BOURLIERE, M., PETTINELLI, M. E., GIRY, C., VALLET‐PICHARD, A., FONTAINE, H., POL, S.

“…Summary Background  The Fib‐4 index is a simple and inexpensive biomarker to delineate liver fibrosis in chronic hepatitis C. Aim  To assess the accuracy of…”
Get full text

The relationship between liver stiffness measurement and outcome in patients with chronic hepatitis C and cirrhosis: a retrospective longitudinal hospital study by Sultanik, P., Kramer, L., Soudan, D., Bouam, S., Meritet, J.‐F., Vallet‐Pichard, A., Fontaine, H., Bousquet, L., Boueyre, E., Corouge, M., Sogni, P., Pol, S., Mallet, V.

“…Summary Background There is a relationship between liver stiffness measurement (LSM) and outcome of HCV patients. Aim To evaluate the performance of LSM to…”
Get full text

Hepatic sinusoidal obstruction syndrome induced by nivolumab in advanced melanoma: a case report by Charvet, E., Lheure, C., Isnard, C., Franck, N., Kramkimel, N., Vallet-Pichard, A., Dohan, A., Terris, B., Aractingi, S., Dupin, N., Guégan, S.

Get full text

Angiographic patterns of in-stent restenosis. Classification and implications for long-term outcome by MEHRAN, R, DANGAS, G, ABIZAID, A. S, MINTZ, G. S, LANSKY, A. J, SATLER, L. F, PICHARD, A. D, KENT, K. M, STONE, G. W, LEON, M. B

“…The angiographic presentation of in-stent restenosis (ISR) may convey prognostic information on subsequent target vessel revascularizations (TLR). We developed…”
Get full text

Realistic multi-cellular dosimetry for 177 Lu-labelled antibodies: model and application by Marcatili, S, Pichard, A, Courteau, A, Ladjohounlou, R, Navarro-Teulon, I, Repetto-Llamazares, A, Heyerdahl, H, Dahle, J, Pouget, J P, Bardiès, M

“…Current preclinical dosimetric models often fail to take account of the complex nature of absorbed dose distribution typical of in vitro clonogenic experiments…”
Get more information

Incidence and correlates of major bleeding after percutaneous coronary intervention across different clinical presentations by Loh, Joshua P., MBBS, Pendyala, Lakshmana K., MD, Torguson, Rebecca, MPH, Chen, Fang, PhD, Satler, Lowell F., MD, Pichard, Augusto A., MD, Waksman, Ron, MD

“…Background Bleeding after percutaneous coronary intervention (PCI) is identified as a strong predictor for adverse events, including mortality. This study aims…”
Get full text

T-cell responses to hepatitis B splice-generated protein of hepatitis B virus and inflammatory cytokines/chemokines in chronic hepatitis B patients. ANRS study: HB EP 02 HBSP-FIBRO by Bayard, F., Godon, O., Nalpas, B., Costentin, C., Zhu, R., Soussan, P., Vallet-Pichard, A., Fontaine, H., Mallet, V., Pol, S., Michel, M.-L.

“…A new hepatitis B virus (HBV) protein, hepatitis B splice‐generated protein (HBSP), has been detected in liver biopsy specimens from patients with chronic…”
Get full text

Non-Tumoral Portalvein Thrombosis and End-Stage Liver Disease in Patients with Cirrhosis: A Longitudinal Retrospective Cohort by Roux, J, Sultanik, P, Bouam, S, Vallet-Pichard, A, Fontaine, H, Corouge, M, Mallet, V, Pol, S, Sogni, P

Get full text

Intracoronary β-radiation therapy inhibits recurrence of In-Stent restenosis by WAKSMAN, R, BHARGAVA, B, KENT, K. K, WHITE, L, CHAN, R. C, MEHRAN, R, LANSKY, A. J, MINTZ, G. S, SATLER, L. F, PICHARD, A. D, LEON, M. B

“…Intracoronary gamma-radiation therapy reduces recurrent in-stent restenosis (ISR). This study, BETA WRIST (Washington Radiation for In-Stent restenosis Trial)…”
Get full text

Patterns and mechanisms of in-stent restenosis : A serial intravascular ultrasound study by HOFFMANN, R, MINTZ, G. S, DUSSAILLANT, G. R, POPMA, J. J, PICHARD, A. D, SATLER, L. F, KENT, K. M, GRIFFIN, J, LEON, M. B

“…Studies have suggested that restenosis within Palmaz-Schatz stents results from neointimal hyperplasia or chronic stent recoil and occurs more frequently at…”
Get full text

Relationship between Alcohol use Disorders and Response to Antiviral Treatment on the Prognosis of Cirrhotic Patients with Chronic Hepatitis C by Sultanik, P, Kramer, L, Bouam, S, Vallet-Pichard, A, Fontaine, H, Corouge, M, Thepot, V, Lavielle, B, Sogni, P, Pol, S, Mallet, V

Get full text

The Relationship between FIB-4 Index Variations and Outcome in Patients with Chronic Hepatitis C and Cirrhosis: Comparison with Liver Stiffness Measurement by Vallet-Pichard, A, Sultanik, P, Meritet, J.F, Bouam, S, Fontaine, H, Corouge, M, Laurain, A, Sogni, P, Pol, S, Mallet, V

Get full text

Retreatment of Sofosbuvir-Including Regimen Failures in the Real Life by Laurain, A, Sultanik, P, Kramer, L, Mertitet, J.-F, Boueyre, E, Mallet, V, Sogni, P, Fontaine, H, Rosenberg, A, Vallet-Pichard, A, Pol, S

Get full text

Emergence of the concept of platelet reactivity monitoring of response to thienopyridines by Bonello, L, De Labriolle, A, Scheinowitz, M, Lemesle, G, Roy, P, Steinberg, D H, Pinto Slottow, T L, Pakala, R, Pichard, A D, Barragan, P, Camoin-Jau, L, Dignat-George, F, Paganelli, F, Waksman, R

“…Clinical trials have demonstrated the beneficial impact of clopidogrel in preventing major adverse cardiovascular events (MACE), particularly in patients…”
Get more information

Late total occlusion after intracoronary brachytherapy for patients with in-stent restenosis by Waksman, Ron, Bhargava, Balram, Mintz, Gary S, Mehran, Roxana, Lansky, Alexandra J, Satler, Lowell F, Pichard, Augusto D, Kent, Kenneth M, Leon, Martin B

“…OBJECTIVES The study sought to determine the incidence and predictors of late total occlusion (LTO, >30 days) in-patients with in-stent restenosis who were…”
Get full text

Arterial remodeling after coronary angioplasty : A serial intravascular ultrasound study by MINTZ, G. S, POPMA, J. J, PICHARD, A. D, KENT, K. M, SATLER, L. F, WONG, S. C, HONG, M. K, KOVACH, J. A, LEON, M. B

“…Restenosis occurs after 30% to 50% of transcatheter coronary procedures; however, the natural history and pathophysiology of restenosis are still incompletely…”
Get full text

The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation by Abizaid, Alexandre, Kornowski, Ran, Mintz, Gary S, Hong, Mun K, Abizaid, Andrea S, Mehran, Roxana, Pichard, Augusto D, Kent, Kenneth M, Satler, Lowell F, Wu, Hongsheng, Popma, Jeffrey J, Leon, Martin B

“…Objectives. We compared the clinical outcomes following coronary stent implantation in insulin-treated diabetes mellitus (IDDM), non-IDDM patients, and…”
Get full text

Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions : Intravascular ultrasound study of 2256 patients by MEHRAN, R, DANGAS, G, MINTZ, G. S, LANSKY, A. J, PICHARD, A. D, SATLER, L. F, KENT, K. M, STONE, G. W, LEON, M. B

“…Elevation of serum creatine kinase MB fraction (CK-MB) after percutaneous coronary interventions has been associated with early and late mortality; however,…”
Get full text

Treatment of calcified coronary lesions with Palmaz-Schatz stents : An intravascular ultrasound study by HOFFMANN, R, MINTZ, G. S, POPMA, J. J, SATLER, L. F, KENT, K. M, PICHARD, A. D, LEON, M. B

“…To evaluate the result of coronary stenting in calcified lesions and to find morphological and procedural factors influencing the final result. Three hundred…”
Get full text

948 INCREASING INCIDENCE OF AUTOIMMUNE HEPATITIS by Corouge, M, Mallet, V, Vallet-Pichard, A, Trabut, J.-B, Tripon, S, Fontaine, H, Sogni, P, Pol, S

Get full text